Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11

Scandinavian Journal of Immunology

Volumn 48, Issue 1, 1998, Pages 103-109

  Jensen, A T R ^a   Gasim, S ^a   Ismail, A ^a,b   Gaafar, A ^a,b   Kurtzhals, J A L ^a   Kemp, M ^a   El Hassan, A M ^b   Kharazmi, A ^a,c   Theander, T G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b National Center for Research Sudan   (Sudan)

^c Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CHILD; FEMALE; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; CELL DIVISION; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTOZOAN PROTEINS;

EID: 0031848371     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00370.x     Document Type: Article

References (36)

1. Andresen K, Gasim S, El Hassan AM et al. Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan. Trop Med Int Health 1997;2:440-4.
2. El Hassan AM, Zijlstra EE, Meredith SEO, Ghalib HW, Ismail A. Identification of Leishmania donovani using a polymerase chain reaction in patients and animal material obtained from an area endemic of kala-azar in the Sudan. Acta Trop 1993;55:87-90.
3. Turco SJ. The lipophosphoglycan of Leishmania. Parasitol Today 1988;4:255-7.
4. Bates PA. The lipophosphoglycan-associated molecules of Leishmania. Parasitol Today 1995;9:317-8.
5. Russel DG, Alexander J. Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J Immunol 1988;140:1274-9.
6. Kemp M, Theander TG, Handman E et al. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand J Immunol 1991;33:219-24.
7. Kurtzhals JAL, Hey AS. Theander TG et al. Cellular and humoral immune responses in a population from the Baringo district, Kenya, to Leishmania promastigote lipophosphoglycan. Am J Trop Med Hyg 1992;46:480-8.
8. Jardim A, Tolson DL, Turco SJ, Pearson TW, Olafson RW. The Leishmania donovani lipophosphoglycan T lymphocyte-reactive component is a tightly associated protein complex. J Immunol 1991;147:3538-544.
9. Mendonça SCF, Russel DG, Coutinho SG. Analysis of the human T cell responsiveness to purified antigens of Leishmania: lipophosphoglycan (LPG) and glycoprotein 63 (gp63). Clin Exp Immunol 1991;83:472-8.
10. Russo DM, Turco SJ, Burns JM, Reed SG. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J Immunol 1992;148:202-7.
11. Jardim A, Funk V, Caprioli RM, Olafson RW. Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein. Biochem J 1995;305:307-13.
12. Jardim A, Hanson S, Ullman B, McCubbin WD, Kay CM, Olafson RW. Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11. Biochem J 1995;305:315-20.
13. Kemp M, Kurtzhals JAL, Christensen CBV et al. Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan associated protein. Immunol Lett 1993;38:137-44.
14. Gaafar A, Kharazmi A, Ismail A et al. Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarity of Th1 activity is associated with severe infections. Clin Exp Immunol 1995;100:239-45.
15. Jensen ATR, Gaafar A, Ismail A et al. Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein. Am J Trop Med Hyg 1996;55:490-5.
16. Kemp M. Kurtzhals JAL, Bendtzen K et al. Leishmania donovanireactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993;61:1069-73.
17. Kurtzhals JAL, Hey AS, Jardim A et al. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol 1994;96:416-21.
18. Kubba R, Al Gindan Y, El Hassan AM, Omer AHS. Clinical diagnosis of cutaneous leishmanaisis (oriental sore). Am J Trop Med Hyg 1987;16:1183-9.
19. Gaafar A, El Kadaro AY, Theander TG et al. The pathology of cutaneous leishmaniasis due to Leishmania major in Sudan. Am J Trop Med Hyg 1995;52:438-42.
20. Hviid L, Theander TG, Jacobsen PH et al. Cell-mediated immune responses to soluble Plasmodium falciparum antigens in residents from an area of unstable malaria transmission in the Sudan. APMIS 1990;98:594-640.
21. Doyle PS, Engel JC, Pimenta PFP, Pinto da Silva P, Dwyer DM. Leishmania donovani: long-term culture of axenic amastigotes at 37°C. Exp Parasitol 1991;73:326-34.
22. Kurtzhals JAL, Hansen MB, Hey AS, Poulsen LK. Measurement of antigen-dependent interleukin-4 production by human peripheral blood mononuclear cells. Introduction of an amplification step using ionomycin and phorbol myristate acetate. J Immunol Methods 1992;156:239-45.
23. Hansen MB, Svenson M, Diamant M, Bendtzen K. Anti-interleukin-6 antibodies in normal human serum. Scand J Immunol 1991;33:777-81.
24. Jakobsen PH, Hviid L, Theander TG et al. Specific T-cell recognition of the merozoite proteins rhoptry-associated protein 1 and erythrocyte-binding antigen 1 of Plasmodium falciparum. Infect Immun 1993;61:268-73.
25. Berberich C, Requena JM, Alonso C. Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein. Exp Parasitol 1997;85:105-8.
26. Haldar JP, Ghose S, Saha KC, Ghose AC. Cell-mediated immune response in Indian kala-azar and post-kala azar dermal leishmaniasis. Infect Immun 1983;42:702-7.
27. Carvalho EM, Teixeira RS, Johnson WD, Jr. Cell-mediated immunity in American visceral leishmaniasis: reversible immuno-suppression during acute infection. Infect Immun 1981;33:498-500.
28. 1 T cells in intracellular infections in humans: leishmaniasis as an example. Immunol Today 1996;17:13-26.
29. Stebeck CE, Beecroft RP, Singh BN et al. Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites. Mol Biochem Parasitol 1995;71:1-13.
30. Facer CA. Direct antiglobulin reactions in Gambian children with P. falciparum malaria. III. Expression of IgG subclass determinants and genetic markers and association with anaemia. Clin Exp Immunol 1980;41:81-90.
31. Theander TG, Hviid L, Dodoo D, Afari EA, Jensen JB, Rzepczyk CM. Human T-cell recognition of synthetic peptides representing conserved and variant sequences from the merozoite surface protein 2 of Plasmodium falciparum. Immunol Lett 1997;58:l-8.
32. Brett SJ, Cease KB, Berzofsky JA. Influences of antigen processing on the expression on the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing. J Exp Med 1988;168:357-73.
33. Mendonça SCF, De-Luca PM, Olafson RW, Jardim A, Coutinho SG. Does lipophospho-glycan enhance the T cell-stimulatory activity of lipophosphoglycan-associated proteins? Braz J Med Biol Res 1994;27:553-57.
34. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-57.
35. Mosmann T, Coffmann R. Th1 and Th2 cells: different patterns of lymphokines activities and secreted proteins. Annu Rev Immunol 1989;7:145-61.
36. Kemp M, Hansen MB, Theander TG. Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals. Infect Immun 1992;60:2246-51.